These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29708514)

  • 21. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
    Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
    J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection.
    Wang M; Wan C; He T; Han C; Zhu K; Waddington JL; Zhen X
    Neuropharmacology; 2021 Sep; 196():108360. PubMed ID: 33122030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective neuronal vulnerability in Parkinson's disease.
    Gonzalez-Rodriguez P; Zampese E; Surmeier DJ
    Prog Brain Res; 2020; 252():61-89. PubMed ID: 32247375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium signaling in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Cell Tissue Res; 2014 Aug; 357(2):439-54. PubMed ID: 24781149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.
    Shi H; Deng HX; Gius D; Schumacker PT; Surmeier DJ; Ma YC
    Hum Mol Genet; 2017 May; 26(10):1915-1926. PubMed ID: 28369333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of cistanoside A on dopaminergic neurons in Parkinson's disease via mitophagy.
    Xu C; Wu Y; Tang L; Liang Y; Zhao Y
    Biotechnol Appl Biochem; 2023 Feb; 70(1):268-280. PubMed ID: 35420720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voltage-Gated Ca
    Ortner NJ
    Front Synaptic Neurosci; 2021; 13():636103. PubMed ID: 33716705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M; Nissanka N; Moraes CT
    J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
    [No Abstract]   [Full Text] [Related]  

  • 33. T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease.
    Tabata Y; Imaizumi Y; Sugawara M; Andoh-Noda T; Banno S; Chai M; Sone T; Yamazaki K; Ito M; Tsukahara K; Saya H; Hattori N; Kohyama J; Okano H
    Stem Cell Reports; 2018 Nov; 11(5):1171-1184. PubMed ID: 30344006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of L-Type Ca
    Sun Y; Zhang H; Selvaraj S; Sukumaran P; Lei S; Birnbaumer L; Singh BB
    J Neurosci; 2017 Mar; 37(12):3364-3377. PubMed ID: 28258168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
    Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
    Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.
    Wang Y; Qu L; Wang XL; Gao L; Li ZZ; Gao GD; Yang Q
    Mol Neurobiol; 2015 Feb; 51(1):424-36. PubMed ID: 24841382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.
    Mori S; Sugama S; Nguyen W; Michel T; Sanna MG; Sanchez-Alavez M; Cintron-Colon R; Moroncini G; Kakinuma Y; Maher P; Conti B
    J Neuroinflammation; 2017 Apr; 14(1):88. PubMed ID: 28427412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium homeostasis, selective vulnerability and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What causes the death of dopaminergic neurons in Parkinson's disease?
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
    Prog Brain Res; 2010; 183():59-77. PubMed ID: 20696315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.